WongMDShapiroMFBoscardinWJet al.Contribution of major diseases to disparities in mortality. N Engl J Med2002; 347: 1585–1592.
2.
Van LaerSDSnijderMBAgyemangCet al.Ethnic differences in hypertension prevalence and contributing variables – the HELIUS. Eur J Prev Cardiol2018; 25: 1914–1922.
3.
WilliamsBManciaGSpieringWet al.2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J2018; 39: 3021–3104.
4.
OngKLCheungBMManYBet al.Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension2007; 49: 69–75.
5.
KramerHHanCPostWet al.Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens2004; 17: 963–970.
6.
LacklandDT. Racial differences in hypertension: Implications for high blood pressure management. Am J Med Sci2014; 348: 135–138.
7.
AldermanMHCohenHWSealeyJEet al.Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients. Am J Hypertens2004; 17: 1–7.
8.
LacklandDTKeilJEGazesPCet al.Outcomes of Black and White hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens1995; 17: 1091–1105.
9.
HowardGPrineasRMoyCet al.Racial and geographic differences in awareness, treatment, and control of hypertension: The REasons for Geographic And Racial Differences in Stroke study. Stroke2006; 37: 1171–1178.
10.
VollmerWMSacksFMArdJet al.Effects of diet and sodium intake on blood pressure: Subgroup analysis of the DASH-sodium trial. Ann Intern Med2001; 135: 1019–1028.
11.
WilliamsSKRavenellJSeyedaliSet al.Hypertension treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines. Prog Cardiovasc Dis2016; 59: 282–288.
12.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA2002; 288: 2981–2997.
13.
WrightJTJrBakrisGGreeneTet al.Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA2002; 288: 2421–2431.
14.
SPRINT Research GroupWrightJTJrWilliamsonJDet al.A randomized trial of intensive versus standard blood-pressure control. N Engl J Med2015; 373: 2103–2116.
15.
WangZHaoGZhangLet al.Central systolic blood pressure is associated with ethnicity and cardiovascular disease risk factors in Chinese middle-aged population. Eur J Prev Cardiol2016; 23: 228–236.
